相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Sanjay J. Mathew et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
What is the value of human FMRI in CNS drug development?
Richard G. Wise et al.
DRUG DISCOVERY TODAY (2010)
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder
Johannes Tauscher et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study
S. Elsenbruch et al.
GUT (2010)
SPINAL CORD MECHANISMS MEDIATING BEHAVIORAL HYPERALGESIA INDUCED BY NEUROKININ-1 TACHYKININ RECEPTOR ACTIVATION IN THE ROSTRAL VENTROMEDIAL MEDULLA
S. C. Lagraize et al.
NEUROSCIENCE (2010)
Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils
Scott A. Heldt et al.
BEHAVIOURAL PHARMACOLOGY (2009)
T1261 The Effect of Chronic Neurokinin-1 Receptor Antagonism On Sympathetic Nervous System Activity in Irritable Bowel Syndrome (IBS)
Kirsten Tillisch et al.
GASTROENTEROLOGY (2009)
NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers
Ciara McCabe et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: A network analysis
J. S. Labus et al.
NEUROIMAGE (2008)
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism
David T. George et al.
SCIENCE (2008)
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats:: a characterization with α/β-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release
Karl Ebner et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
A validated network of effective amygdalla connectivity
Jason L. Stein et al.
NEUROIMAGE (2007)
The NK1-receptor antagonist TKA731 in painful diabetic neuropathy:: A randomised, controlled trial
Soren H. Sindrup et al.
EUROPEAN JOURNAL OF PAIN (2006)
Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
M Keller et al.
BIOLOGICAL PSYCHIATRY (2006)
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo
T Furmark et al.
BIOLOGICAL PSYCHIATRY (2005)
Peptides that fine-tune the serotonin system
RJ Valentino et al.
NEUROPEPTIDES (2005)
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression
MS Kramer et al.
NEUROPSYCHOPHARMACOLOGY (2004)
The positive and negative affect schedule (PANAS): Construct validity, measurement properties and normative data in a large non-clinical sample
JR Crawford et al.
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2004)
Prevalence of irritable bowel syndrome among university students - The roles of worry, neuroticism, anxiety sensitivity and visceral anxiety
H Hazlett-Stevens et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2003)
Inflammatory bowel disease and irritable bowel syndrome: separate or unified?
S Bradesi et al.
CURRENT OPINION IN GASTROENTEROLOGY (2003)
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways
R Suzuki et al.
NATURE NEUROSCIENCE (2002)
Effects of tachykinin NK1 receptor antagonists viscerosensory response caused by colorectal in rabbits
S Okano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Lanepitant, an NK-1 antagonist, in migraine prevention
DJ Goldstein et al.
CEPHALALGIA (2001)
Neuroanatomical localisation of substance P in the CNS and sensory neurons
A Ribeiro-da-Silva et al.
NEUROPEPTIDES (2000)
Study of the analgesic effect of lanepitant in patients with osteoarthritis pain
DJ Goldstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene
JMA Laird et al.
NEUROSCIENCE (2000)
分享论文
